These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26250055)

  • 1. Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection.
    Rembeck K; Lagging M
    Pharmacogenomics; 2015; 16(10):1179-88. PubMed ID: 26250055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of human gene polymorphisms on HCV infection and disease outcome.
    Schaefer EA; Chung RT
    Semin Liver Dis; 2011 Nov; 31(4):375-86. PubMed ID: 22189977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.
    Rembeck K; Waldenström J; Hellstrand K; Nilsson S; Nyström K; Martner A; Lindh M; Norkrans G; Westin J; Pedersen C; Färkkilä M; Langeland N; Buhl MR; Mørch K; Christensen PB; Lagging M
    Hepatology; 2014 Jun; 59(6):2131-9. PubMed ID: 24519039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
    Tamaki N; Kurosaki M; Higuchi M; Takada H; Nakakuki N; Yasui Y; Suzuki S; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Ogawa S; Tanaka Y; Asahina Y; Izumi N
    PLoS One; 2015; 10(9):e0137351. PubMed ID: 26352693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus.
    Nyström K; Wanrooij PH; Waldenström J; Adamek L; Brunet S; Said J; Nilsson S; Wind-Rotolo M; Hellstrand K; Norder H; Tang KW; Lagging M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B type.
    Matsuura K; Tanaka Y; Watanabe T; Fujiwara K; Orito E; Kurosaki M; Izumi N; Sakamoto N; Enomoto N; Yatsuhashi H; Kusakabe A; Shinkai N; Nojiri S; Joh T; Mizokami M
    J Viral Hepat; 2014 Jul; 21(7):466-74. PubMed ID: 24750345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.
    Moritou Y; Ikeda F; Iwasaki Y; Baba N; Takaguchi K; Senoh T; Nagano T; Takeuchi Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Yamamoto K
    Acta Med Okayama; 2014; 68(1):17-22. PubMed ID: 24553484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.
    Di Marco V; Calvaruso V; Grimaudo S; Ferraro D; Pipitone RM; Di Stefano R; Craxì A
    J Viral Hepat; 2013 Feb; 20(2):113-21. PubMed ID: 23301546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining baseline demographics: the role of genetic testing in hepatitis C virus infection.
    Holmes JA; Desmond PV; Thompson AJ
    Clin Liver Dis; 2011 Aug; 15(3):497-513. PubMed ID: 21867933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
    Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
    Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of ITPA and IL28B genotypes in chronic Hepatitis C patients treated with peginterferon plus ribavirin in Tunisian population.
    Sghaier I; Mouelhi L; Gazouani E; Morel V; Besma YL; Brochot E
    J Clin Virol; 2015 Aug; 69():184-9. PubMed ID: 26209404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
    Seto WK; Tsang OT; Liu K; Chan JM; Wong DK; Fung J; Lai CL; Yuen MF
    J Viral Hepat; 2013 Jul; 20(7):470-7. PubMed ID: 23730840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients.
    Enache EL; Sin A; Bancu L; Ramière C; Diaz O; André P; Enache LS
    Int J Mol Sci; 2015 Sep; 16(9):22223-42. PubMed ID: 26389885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
    Vasanthakumar A; Davis JW; Abunimeh M; Söderholm J; Zha J; Dumas EO; Cohen DE; Waring JF; Lagging M
    PLoS One; 2018; 13(5):e0198296. PubMed ID: 29851985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S; Maida M; Grimaudo S; Pipitone RM; Macaluso FS; Cabibi D; Cammà C; Di Marco V; Sferrazza S; Craxì A
    Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
    About F; Oudot-Mellakh T; Niay J; Rabiéga P; Pedergnana V; Duffy D; Sultanik P; Cagnot C; Carrat F; Marcellin P; Zoulim F; Larrey D; Hézode C; Fontaine H; Bronowicki JP; Pol S; Albert ML; Theodorou I; Cobat A; Abel L;
    PLoS One; 2015; 10(12):e0145105. PubMed ID: 26670100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment.
    Zampino R; Alessio L; Marrone A; Stanzione M; Boemio A; Grandone A; Minichini C; Pisaturo M; Starace M; Adinolfi LE; Sagnelli E; Coppola N
    Infez Med; 2015 Jun; 23(2):134-9. PubMed ID: 26110293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.